Paper37423945
Bone marrow adipoq+ cell population controls bone mass via sclerostin in mice.
Gao H and 5 others. Signal Transduct Target Ther, 2023. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Bone marrow adipoq+ cell population controls bone mass via sclerostin in mice. Papers, record 37423945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37423945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow | Major topic |
| Population Control | Major topic |
| Mice | |
| Animals | |
| Bone Density | |
| Osteoblasts |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18269310 | Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. | J Bone Miner Res | 2008 | https://conductscience.org/library/papers/18269310 | PubMed |
| 2 | 31127816 | Bone Marrow Adiposity: Basic and Clinical Implications. | Endocr Rev | 2019 | https://conductscience.org/library/papers/31127816 | PubMed |
| 3 | 33027637 | Ablation of Fat Cells in Adult Mice Induces Massive Bone Gain. | Cell Metab | 2020 | https://conductscience.org/library/papers/33027637 | PubMed |
| 4 | 32040934 | The Osteocyte: New Insights. | Annu Rev Physiol | 2020 | https://conductscience.org/library/papers/32040934 | PubMed |
| 5 | 35869074 | Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation. | Nat Commun | 2022 | https://conductscience.org/library/papers/35869074 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42662722 | Bone marrow adipoq-lineage cells in regulating the bone and marrow microenvironment: identities, functions, and mechanisms. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42662722 | PubMed |
| 42575886 | Youthfulness of marrow Adipoq+ cells maintained by Cbfβ facilitates stem cell-based bone repair. | Bone Res | 2026 | https://conductscience.org/library/papers/42575886 | PubMed |
| 42518655 | Biomaterials at the interface of bone-derived factors and inter-organ communication: Current evidence and future perspectives. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42518655 | PubMed |
| 42359046 | Interorgan Communications in Skeletal Pathophysiology: From Molecular Pathways to Multidisciplinary Therapies. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42359046 | PubMed |
| 41195108 | Adiponectin expressing skeletal stem/progenitor cells in the bone and bone marrow homeostasis. | Curr Opin Endocr Metab Res | 2024 | https://conductscience.org/library/papers/41195108 | PubMed |
| 40999873 | The Sirt1-Piezo1 Axis Promotes Bone Formation and Repair in Mice. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40999873 | PubMed |
| 40847364 | Leptin receptor signaling mediates the distinct tendon-bone interface reconstruction in rotator cuff tears and osteoporosis-comorbid rotator cuff tears. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40847364 | PubMed |
| 40845776 | The protective role of adipogenic lineage precursors in maintaining bone marrow redox homeostasis in a mouse model of prenatal dexamethasone exposure. | Redox Biol | 2025 | https://conductscience.org/library/papers/40845776 | PubMed |
| 40307216 | Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs. | Bone Res | 2025 | https://conductscience.org/library/papers/40307216 | PubMed |
| 39875754 | Sex-specific transcriptomic profiling reveals key players in bone loss associated with Alzheimer's disease. | Geroscience | 2025 | https://conductscience.org/library/papers/39875754 | PubMed |
| 39524152 | FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism. | J Orthop Translat | 2024 | https://conductscience.org/library/papers/39524152 | PubMed |
| 39490735 | Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: A prospective cohort study. | J Adv Res | 2025 | https://conductscience.org/library/papers/39490735 | PubMed |
| 39362888 | Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity. | Nat Commun | 2024 | https://conductscience.org/library/papers/39362888 | PubMed |
| 38562782 | IFT20 and WWTR1 govern bone homeostasis via synchronously regulating the expression and stability of TβRII in osteoblast lineage cells. | Res Sq | 2024 | https://conductscience.org/library/papers/38562782 | PubMed |
| 38549808 | Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow. | J Orthop Translat | 2024 | https://conductscience.org/library/papers/38549808 | PubMed |
| 38495744 | Pip5k1c expression in osteocytes regulates bone remodeling in mice. | J Orthop Translat | 2024 | https://conductscience.org/library/papers/38495744 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37423945
GET https://conductscience.org/api/papers/v1/37423945/authors